Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi)
Authors:
- Uta FuchsUFUta Fuchs
- Wilhelm WössmannWWWilhelm Wössmann
- Arndt BorkhardtABArndt Borkhardt
- 13 August 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (37) , 5716-5724
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 36 references indexed in Scilit:
- Expanding small RNA interferenceNature Biotechnology, 2002
- Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysateThe EMBO Journal, 2001
- Roots of Clinical Resistance to STI-571 Cancer TherapyScience, 2001
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Chronic Myelogenous LeukemiaHematology-American Society Hematology Education Program, 2001
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996
- Antisense oligodeoxynucleotidesCurrent Opinion in Oncology, 1994
- Reaktionen der Trialkylsilyl‐trifluormethansulfonate, IX. Elektrophile Silylierung elektronenreicher AlkeneEuropean Journal of Organic Chemistry, 1990